Correlation Between Cingulate Warrants and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Conduit Pharmaceuticals.
Diversification Opportunities for Cingulate Warrants and Conduit Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and Conduit is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Conduit Pharmaceuticals
Assuming the 90 days horizon Cingulate Warrants is expected to generate 2.43 times less return on investment than Conduit Pharmaceuticals. But when comparing it to its historical volatility, Cingulate Warrants is 1.34 times less risky than Conduit Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 1.31 in Conduit Pharmaceuticals on September 5, 2024 and sell it today you would earn a total of 0.69 from holding Conduit Pharmaceuticals or generate 52.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 57.14% |
| Values | Daily Returns |
Cingulate Warrants vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Cingulate Warrants |
| Conduit Pharmaceuticals |
Cingulate Warrants and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Conduit Pharmaceuticals
The main advantage of trading using opposite Cingulate Warrants and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd |
| Conduit Pharmaceuticals vs. Candel Therapeutics | Conduit Pharmaceuticals vs. Cingulate Warrants | Conduit Pharmaceuticals vs. Unicycive Therapeutics | Conduit Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world |